- Home
- HIO vs ESPR Comparison
HIO vs ESPR Comparison
Compare HIO & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIO
- ESPR
- Stock Information
- Founded
- HIO 1993
- ESPR 2008
- Country
- HIO United States
- ESPR United States
- Employees
- HIO N/A
- ESPR N/A
- Industry
- HIO Finance/Investors Services
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- HIO Finance
- ESPR Health Care
- Exchange
- HIO Nasdaq
- ESPR Nasdaq
- Market Cap
- HIO 379.0M
- ESPR 305.0M
- IPO Year
- HIO N/A
- ESPR 2013
- Fundamental
- Price
- HIO $3.95
- ESPR $1.39
- Analyst Decision
- HIO
- ESPR Buy
- Analyst Count
- HIO 0
- ESPR 7
- Target Price
- HIO N/A
- ESPR $6.36
- AVG Volume (30 Days)
- HIO 305.3K
- ESPR 4.5M
- Earning Date
- HIO 01-01-0001
- ESPR 03-04-2025
- Dividend Yield
- HIO 10.33%
- ESPR N/A
- EPS Growth
- HIO N/A
- ESPR N/A
- EPS
- HIO N/A
- ESPR N/A
- Revenue
- HIO N/A
- ESPR $332,314,000.00
- Revenue This Year
- HIO N/A
- ESPR $5.51
- Revenue Next Year
- HIO N/A
- ESPR $1.42
- P/E Ratio
- HIO N/A
- ESPR N/A
- Revenue Growth
- HIO N/A
- ESPR 185.66
- 52 Week Low
- HIO $3.52
- ESPR $1.35
- 52 Week High
- HIO $4.03
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- HIO 35.15
- ESPR 33.54
- Support Level
- HIO $4.03
- ESPR $1.35
- Resistance Level
- HIO $4.04
- ESPR $1.75
- Average True Range (ATR)
- HIO 0.04
- ESPR 0.09
- MACD
- HIO -0.01
- ESPR -0.01
- Stochastic Oscillator
- HIO 5.88
- ESPR 10.00
About HIO Western Asset High Income Opportunity Fund Inc.
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests in various sectors such as auto components, hotels, restaurants and leisure, household durables, food & staples, energy, banks, capital markets, consumer finance, insurance, pharmaceuticals, aerospace and defense, and others.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.